Literature DB >> 6820432

Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet.

S D Cederbaum, S J Moedjono, K N Shaw, M Carter, E Naylor, M Walzer.   

Abstract

A brother and sister aged 11 and 17 years have been reported previously to have hyperargininaemia and arginase deficiency: they were treated with a semi-synthetic diet consisting of fat, carbohydrate, minerals, vitamins and essential amino acids in amounts equivalent to 0.55-0.65 g protein kg-1 day-1 for 2 years. Plasma arginine levels fell from 0.50-0.90 mumol/1 to 0.13-0.30 mumol/1 (normal range 0.02-0.15). Increased concentrations of arginine in the cerebrospinal fluid (CSF) fell from 0.069-0.098 mumol/l to 0.040-0.056 mumol/l (normal mean +/- SD = 0.020 +/- 0.006). Dibasic aminoaciduria returned to normal within 1 week. Substitution of the keto-acid analogues of five essential amino acids in the formula lowered arginine concentrations further, but proved to be unpalatable. Urinary concentrations of orotic acid, uridine and uracil fell toward normal but remained increased, even when the plasma ammonia concentration was measured as normal. Both patients showed a stable clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6820432     DOI: 10.1007/bf01800000

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

1.  Treatment of carbamyl phosphate synthetase deficiency with keto analogues of essential amino acids.

Authors:  M Batshaw; S Brusilow; M Walser
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

2.  A kinetic determination of ammonia in plasma.

Authors:  H A Jacobs; F M Olthuis
Journal:  Clin Chim Acta       Date:  1973-01-10       Impact factor: 3.786

3.  Familial hyperargininemia.

Authors:  H G Terheggen; F Lavinha; J P Colombo; M Van Sande; A Lowenthal
Journal:  J Genet Hum       Date:  1972-03

4.  Argininemia treated from birth.

Authors:  S E Snyderman; C Sansaricq; P M Norton; F Goldstein
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

5.  The free amino acids of human spinal fluid determined by ion exchange chromatography.

Authors:  J C Dickinson; P B Hamilton
Journal:  J Neurochem       Date:  1966-11       Impact factor: 5.372

6.  The therapy of hyperammonemia due to ornithine transcarbamylase defiency in a male neonate.

Authors:  S E Snyderman; C Sansaricq; S V Phansalkar; R C Schacht; P M Norton
Journal:  Pediatrics       Date:  1975-07       Impact factor: 7.124

7.  Hyperargininemia with arginase deficiency.

Authors:  S D Cederbaum; K N Shaw; E B Spector; M A Verity; P J Snodgrass; G I Sugarman
Journal:  Pediatr Res       Date:  1979-07       Impact factor: 3.756

8.  Arginase deficiency in multiple tissues in argininemia.

Authors:  V V Michels; A L Beaudet
Journal:  Clin Genet       Date:  1978-01       Impact factor: 4.438

9.  Argininemia.

Authors:  S E Snyderman; C Sansaricq; W J Chen; P M Norton; S V Phansalkar
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

10.  Urinary pyrimidine excretion in arginase deficiency.

Authors:  E W Naylor; S D Cederbaum
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

View more
  15 in total

1.  A new case of hyperargininaemia: neurological and biochemical findings prior to and during dietary treatment.

Authors:  M Brockstedt; L M Smit; A J de Grauw; J M van der Klei-van Moorsel; C Jakobs
Journal:  Eur J Pediatr       Date:  1990-02       Impact factor: 3.183

Review 2.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

3.  Arginase deficiency in two brothers.

Authors:  M Candito; B Bebin; C Vianey-Saban; D Rabier; S Bekri; F Sebag; P Chambon; P Kamoun
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease.

Authors:  J R Bonham; P Guthrie; M Downing; J C Allen; M S Tanner; M Sharrard; C Rittey; J M Land; A Fensom; D O'Neill; J A Duley; L D Fairbanks
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

Review 5.  Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency.

Authors:  Fernando Scaglia; Brendan Lee
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

6.  A new French-Canadian family affected by hyperargininaemia.

Authors:  I A Qureshi; J Letarte; R Ouellet; J Larochelle; B Lemieux
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

Review 7.  The human arginases and arginase deficiency.

Authors:  R Iyer; C P Jenkinson; J G Vockley; R M Kern; W W Grody; S Cederbaum
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

8.  Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme.

Authors:  W W Grody; R M Kern; D Klein; A E Dodson; P B Wissman; S H Barsky; S D Cederbaum
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

9.  Increased urinary excretion of putrescine in hyperargininaemia.

Authors:  T Kato; M Sano; N Mizutani; C Hayakawa
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

10.  Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency.

Authors:  Lindsay C Burrage; Qin Sun; Sarah H Elsea; Ming-Ming Jiang; Sandesh C S Nagamani; Arthur E Frankel; Everett Stone; Susan E Alters; Dale E Johnson; Scott W Rowlinson; George Georgiou; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2015-09-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.